CALC
CalciMedica Inc

3,390
Mkt Cap
$45.48M
Volume
10,983.00
52W High
$4.26
52W Low
$1.42
PE Ratio
-1.97
CALC Fundamentals
Price
$3.22
Prev Close
$3.16
Open
$3.25
50D MA
$3.13
Beta
0.45
Avg. Volume
43,899.00
EPS (Annual)
-$1.22
P/B
-167.87
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates...
PR Newswire·8d ago
News Placeholder
More News
News Placeholder
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension CalciMedica Announces Publication in...
PR Newswire·8d ago
News Placeholder
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora CalciMedica and Telperian Announce Collaboration to...
PR Newswire·1mo ago
News Placeholder
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference...
PR Newswire·9mo ago
News Placeholder
CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference PR Newswire...
PR Newswire·10mo ago
News Placeholder
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors PR Newswire LA JOLLA, Calif., Jan. 14, 2025...
PR Newswire·10mo ago
News Placeholder
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference PR Newswire LA JOLLA, Calif., Nov...
PR Newswire·1y ago
News Placeholder
CalciMedica Announces Presentations at Upcoming Medical Meetings
CalciMedica Announces Presentations at Upcoming Medical Meetings CalciMedica Announces Presentations at Upcoming Medical Meetings PR Newswire LA JOLLA, Calif., Nov. 20, 2024 Prof. Robert Sutton...
PR Newswire·1y ago
News Placeholder
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates...
PR Newswire·1y ago
News Placeholder
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial...
PR Newswire·1y ago

Latest CALC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.